Isoriac

Isotretinoin, the active ingredient in Isoriac, is a retinoid presented as an oral formulation for systemic use. It is prescribed for severe nodular acne and other forms of acne vulgaris in patients who have not responded adequately to conventional therapies. Isoriac is supplied as a prescription‑only product and is classified in pregnancy category X due to its high teratogenic risk.

GNH USA supplies Isoriac as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Isoriac is a retinoid that targets the pathophysiology of acne and related skin disorders.

Severe nodular acne: reduces lesion count and prevents new nodule formation. Acne vulgaris (moderate to severe): normalizes follicular keratinization and decreases sebum output. Acne resistant to topical and oral antibiotics: provides an alternative mechanism when other treatments have failed.

Isotretinoin is associated with a range of adverse reactions that vary in frequency and severity.

Common Side Effects: - Dry skin and mucous membranes, including cheilitis. - Photosensitivity leading to easy sunburn. - Elevated liver enzymes and triglyceride levels. - Transient headache or